Revolutions Medical CORP: 10-Q/A filed 2011-10-21

Name: Revolutions Medical CORP: 10-Q/A filed 2011-10-21
Creator: Revolutions Medical CORP

What Revolutions Medical CORP reported in its quarterly report amendment filed 2011-10-21 (fiscal Q2 2011): 27 published measures, 80 facts as tagged in accession 0001144204-11-058850.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form: 10-Q/A (quarterly report amendment)
Filed: 2011-10-21
Fiscal period: fiscal Q2 2011
Accession: 0001144204-11-058850 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Revolutions Medical CORP filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2011-06-30	1,578,140	USD
At 2010-12-31	1,234,028	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2011-06-30	2,313,244	USD
At 2010-12-31	1,581,108	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2011-06-30	-735,103	USD
At 2010-12-31	-347,080	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2011-06-30	25,287	USD
At 2010-12-31	69,517	USD
At 2010-06-30	170	USD
At 2009-12-31	67,228	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	-1,198,603	USD	91
2011-01-01 to 2011-06-30	-2,082,138	USD	181
1996-08-16 to 2011-06-30	-27,658,889	USD	5432
2010-04-01 to 2010-06-30	-15,268	USD	91
2010-01-01 to 2010-06-30	-239,372	USD	181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2011-01-01 to 2011-06-30	-1,455,425	USD	181
1996-08-16 to 2011-06-30	-9,563,936	USD	5432
2010-01-01 to 2010-06-30	-343,549	USD	181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2011-01-01 to 2011-06-30	363,706	USD	181
1996-08-16 to 2011-06-30	1,252,808	USD	5432
2010-01-01 to 2010-06-30	109,509	USD	181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2011-01-01 to 2011-06-30	1,793,901	USD	181
1996-08-16 to 2011-06-30	11,355,595	USD	5432
2010-01-01 to 2010-06-30	386,000	USD	181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2011-01-01 to 2011-06-30	-382,706	USD	181
1996-08-16 to 2011-06-30	-1,568,805	USD	5432
2010-01-01 to 2010-06-30	-109,509	USD	181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2011-06-30	-27,533,890	USD
At 2010-12-31	-25,451,751	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2011-06-30	1,173,032	USD
At 2010-12-31	812,478	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
1996-08-16 to 2011-06-30	2,018,280	USD	5432

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	-1,108,599	USD	91
2011-01-01 to 2011-06-30	-1,935,534	USD	181
1996-08-16 to 2011-06-30	-27,459,143	USD	5432
2010-04-01 to 2010-06-30	24,937	USD	91
2010-01-01 to 2010-06-30	-204,365	USD	181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2011-06-30	337,832	USD
At 2010-12-31	373,274	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	112,292	USD	91
2011-01-01 to 2011-06-30	190,828	USD	181
1996-08-16 to 2011-06-30	475,940	USD	5432
2010-04-01 to 2010-06-30	47,121	USD	91
2010-01-01 to 2010-06-30	56,188	USD	181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2011-06-30	2,313,244	USD
At 2010-12-31	1,581,108	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2011-06-30	23,276	USD
At 2010-12-31	23,276	USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

Period	Value	Unit	Days
1996-08-16 to 2011-06-30	969	USD	5432

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	1,108,599	USD	91
2011-01-01 to 2011-06-30	1,935,534	USD	181
1996-08-16 to 2011-06-30	27,459,143	USD	5432
2010-04-01 to 2010-06-30	-24,937	USD	91
2010-01-01 to 2010-06-30	204,365	USD	181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	111,832	USD	91
2011-01-01 to 2011-06-30	111,832	USD	181
1996-08-16 to 2011-06-30	6,264,753	USD	5432

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2011-06-30	49,178,580	shares
At 2010-12-31	42,869,909	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2011-06-30	26,749,077	USD
At 2010-12-31	25,061,270	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	995,148	USD	91
2011-01-01 to 2011-06-30	1,820,549	USD	181
1996-08-16 to 2011-06-30	21,140,019	USD	5432
2010-04-01 to 2010-06-30	-26,427	USD	91
2010-01-01 to 2010-06-30	201,385	USD	181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	1,619	USD	91
2011-01-01 to 2011-06-30	3,153	USD	181
1996-08-16 to 2011-06-30	54,371	USD	5432
2010-04-01 to 2010-06-30	1,490	USD	91
2010-01-01 to 2010-06-30	2,980	USD	181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2011-01-01 to 2011-06-30	3,153	USD	181
1996-08-16 to 2011-06-30	88,620	USD	5432
2010-01-01 to 2010-06-30	2,980	USD	181

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
1996-08-16 to 2011-06-30	205,327	USD	5432

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	-90,003	USD	91
2011-01-01 to 2011-06-30	-146,604	USD	181
1996-08-16 to 2011-06-30	-383,168	USD	5432
2010-04-01 to 2010-06-30	-40,205	USD	91
2010-01-01 to 2010-06-30	-35,007	USD	181

Inspect the source

Entity: Revolutions Medical CORP / CIK 0001041009
Captured: 2026-09-22 19:37 UTC
SEC response SHA-256: 147399b6fb66b811b6d2c30d5167ca16121e9239b95a8a07106a6bdf6bbf37d5

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001041009.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))